Acne 

Actinic Keratosis 

Aesthetics

Alopecia

Biologic Treatments for Moderate to Severe Atopic Dermatitis 

Atopic Dermatitis 

Buy-and-Bill

COVID-19

Case-Based Roundtable

Chronic Hand Eczema

Drug Watch

Eczema

General Dermatology 

Hidradenitis Suppurativa

Melasma

NP and PA

Pediatric Dermatology

Pigmentary Disorders 

Practice Management 

Precision Medicine and Biologics

Prurigo Nodularis

Emerging Therapies Plaque Psoriasis

Treatments for Plaque Psoriasis 

Psoriasis 

Psoriatic Arthritis 

Rare Disease

Rosacea 

Skin Cancer (Nonmelanoma)

Skin Cancer

Vitiligo

Wound Care

News

Media

Around the Practice

Between The Lines

Case-Based Peer Perspective

Clinical Case Collective

DermView

Expert Perspectives

Fellows Face Off

Frontline Forum

Medical World News

Patient Perspectives

Podcasts

Readout360

Recognize and Refer

Conferences

Conference Coverage

Conference Listing

Events

Publication

Dermatology Times

CME/CE

Resources

DermIQ

Interactive Tools

Job Board

Partner Perspectives

Perspectives in Dermatology

Polls

Editorial Advisory Board

Partners

Subscribe

and joined the MJH Life Sciences team in February 2023. She attended Kent State University and earned a Bachelor of Science degree in journalism with minors in public relations and creative writing. She enjoys making and listening to music, reading, and spending time with her cats, Astrid and Marceline.

Articles

The phase 2 trial of bimiralisib gel shows promising efficacy and safety for actinic keratosis, with up to 70% lesion clearance.

Torqur AG Reports Promising Phase 2 Results for Bimiralisib Gel in Actinic Keratosis

Maddi Hebebrand is an associate editor of 

and joined the MJH Life Sciences team in May 2024. She attended Baldwin Wallace University, studying Media Production and Film, and is now finishing her Masters in Digital Media through Ohio University. When she's not writing, Maddi loves to read, attend concerts and spend time with her family.

In addition to Taylor, several other new leaders have been appointed to key roles within the AAD to help drive its mission of advancing dermatology.

AAD Announces Newly Appointed Leadership Officers

Marie Bosslett is the assistant editor of 

 and joined the MJH Life Sciences team in October 2024. She attended Loyola University Maryland in Baltimore and earned a Bachelor of Arts in Communication with minors in marketing and writing. When she’s not writing, Marie enjoys going to concerts, reading on the beach, and spending time with friends and family.

Along with his session insights on diet and chronic spontaneous urticaria, Friedman shares tips for navigating the largest dermatology conference in the US.

Adam Friedman, MD, FAAD: Expert Insights and Advice on Navigating AAD

Ahead of the annual meeting, Dermatology Times spoke with Draelos about why she looks forward to the meeting each year.

Zoe Diana Draelos, MD: Gearing Up for AAD

About

Advertise

Contact Us

Do Not Sell My Information

Terms and Conditions

Privacy Policy

Dermatology Times and Multimedia Medical, LLC

Facebook

Linkedin

Topics

Acne

Pigmentary Disorders

Practice Management

Psoriasis

Psoriatic Arthritis

Rosacea

1rem

View

New Treatment Technology for Treating Warts

Video Series

Traditional vs Microwave Wart Therapies: Insights from Swift’s Efficacy Data

Videos

Join Dustin Portela, DO, as he delves into Swift microwave therapy, exploring its science, effectiveness, and impact on wart management. In this series, he will discuss patient care and comfort as well as practice efficiencies.

Dustin Portela, DO, introduces the topic of Swift technology and how this microwave therapy is revolutionizing wart treatment by activating the immune system to fight off viral infections naturally.

Introduction of Swift Microwave Therapy for Wart Treatment

In this episode, Dustin Portela, DO, discusses how treating warts can be a challenge and explores the effectiveness of Swift microwave therapy. The episode reviews how this innovative approach compares to traditional methods and helps patients achieve lasting results.

In this episode, Dustin Portela, DO, explores how Swift microwave therapy is transforming wart treatment, the science behind this technology, and how it reduces wart-related pain.

Microwave Treatment: Advantages Over Traditional Approaches

Dustin Portela, DO, discusses patient selection and affordability considerations for Swift microwave therapy. He explores how the treatment process works and strategies to ensure patient comfort during sessions.

Patient Selection and Billing Considerations for Swift Wart Treatment

In this episode, Dustin Portela, DO, explores how Swift microwave therapy enhances efficiency and allows physicians to focus on other aspects of care.

Practicing With Swift: Impacts and Opportunities Created

Dustin Portela, DO, highlights how the design of Swift microwave therapy improves efficiency, simplifies training for medical assistants, and enhances practice flexibility.

Operational Benefits With Swift As a Delegable Procedure

Dustin Portela, DO, discuss how Swift microwave therapy can enhance patient care, generate referrals, and offer a promising revenue stream, while keeping pace with ongoing advancements in the technology.

Key Takeaways for Adding Swift Wart Treatment to Your Practice

Traditional vs Microwave Wart Therapies: Insights from Swift’s Efficacy Data

EP: 1.Introduction of Swift Microwave Therapy for Wart Treatment

EP: 2.Traditional vs Microwave Wart Therapies: Insights from Swift’s Efficacy Data

EP: 3.Microwave Treatment: Advantages Over Traditional Approaches

EP: 4.Patient Selection and Billing Considerations for Swift Wart Treatment

EP: 5.Practicing With Swift: Impacts and Opportunities Created

EP: 6.Operational Benefits With Swift As a Delegable Procedure

EP: 7.Key Takeaways for Adding Swift Wart Treatment to Your Practice